Corporate Governance
At Nanodose Therapeutics, we believe that strong corporate governance is essential for the long-term success of our company. We are committed to transparency, ethics, and accountability in all aspects of our business, and strive to ensure that our decision-making process is always guided by the best interests of our company and its stakeholders.
Committees
Member
Audit & Risk
Committee
Remuneration
Committee
Nomination & Corporate Governance Committee
Dick Sandberg
CEO & Co-Chairman
X
X
X
John McMichael
Scientific Founder & Co-Chairman
X
X
X
Tom Hatch
Executive Vice President
X
X
X
Stephen Hill
Lead Director
X
X
X
Damian Marron
Non-Executive Director
X
X
X
McKay Belk
Non-Executive Director
X
X
X
Charters & Policies
Committee Terms of Reference
Audit Committee
Remuneration Committee
Nomination & Corporate Governance Committee
Governance Documents
Articles of Association
Code of Business Conduct & Ethics
Corporate Governance Guidelines
Supplier Code of Conduct
Nanodose Therapeutics Forward-Looking Statement
The information contained in this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements may be identified through the use of words such as “may”, "expects/excepted", "will", "anticipates", “allows”, "estimates", "believes", “provides” or by statements indicating certain actions "may", "could", "should" or "might" occur. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The information contained in this website was current as of the date prepared and we specifically disclaim any obligation to update any forward-looking statements, whether as a result of new information, future developments, or otherwise.
Version: 04.01.2024